Cooper Other Non-Current Liabilities 2010-2024 | COO
Cooper other non-current liabilities from 2010 to 2024. Other non-current liabilities can be defined as field containing the sum of all non-current liabilities that cannot be standardized into another field as well as those that are aggregated by the company because materially, they are too small to list separately.
- Cooper other non-current liabilities for the quarter ending October 31, 2024 were $0.369B, a 12.05% increase year-over-year.
- Cooper other non-current liabilities for 2024 were $0.369B, a 12.05% increase from 2023.
- Cooper other non-current liabilities for 2023 were $0.329B, a 2.66% decline from 2022.
- Cooper other non-current liabilities for 2022 were $0.338B, a 142.41% increase from 2021.
Cooper Annual Other Non-Current Liabilities
(Millions of US $) |
| 2024 |
$369 |
| 2023 |
$329 |
| 2022 |
$338 |
| 2021 |
$140 |
| 2020 |
$162 |
| 2019 |
$125 |
| 2018 |
$142 |
| 2017 |
$ |
| 2016 |
$ |
| 2015 |
$ |
| 2014 |
$ |
| 2013 |
$ |
| 2012 |
$ |
| 2011 |
$ |
| 2010 |
$ |
| 2009 |
$ |
Cooper Quarterly Other Non-Current Liabilities
(Millions of US $) |
| 2024-10-31 |
$369 |
| 2024-07-31 |
$336 |
| 2024-04-30 |
$337 |
| 2024-01-31 |
$370 |
| 2023-10-31 |
$329 |
| 2023-07-31 |
$91 |
| 2023-04-30 |
$91 |
| 2023-01-31 |
$112 |
| 2022-10-31 |
$338 |
| 2022-07-31 |
$117 |
| 2022-04-30 |
$126 |
| 2022-01-31 |
$138 |
| 2021-10-31 |
$140 |
| 2021-07-31 |
$140 |
| 2021-04-30 |
$150 |
| 2021-01-31 |
$165 |
| 2020-10-31 |
$162 |
| 2020-07-31 |
$162 |
| 2020-04-30 |
$159 |
| 2020-01-31 |
$176 |
| 2019-10-31 |
$125 |
| 2019-07-31 |
$125 |
| 2019-04-30 |
$125 |
| 2019-01-31 |
$125 |
| 2018-10-31 |
$142 |
| 2018-07-31 |
$171 |
| 2018-04-30 |
$176 |
| 2018-01-31 |
$176 |
| 2017-10-31 |
|
| 2017-07-31 |
|
| 2017-04-30 |
|
| 2017-01-31 |
|
| 2016-10-31 |
|
| 2016-07-31 |
|
| 2016-04-30 |
|
| 2016-01-31 |
|
| 2015-10-31 |
|
| 2015-07-31 |
|
| 2015-04-30 |
|
| 2015-01-31 |
|
| 2014-10-31 |
|
| 2014-07-31 |
|
| 2014-04-30 |
|
| 2014-01-31 |
|
| 2013-10-31 |
|
| 2013-07-31 |
|
| 2013-04-30 |
|
| 2013-01-31 |
|
| 2012-10-31 |
|
| 2012-07-31 |
|
| 2012-04-30 |
|
| 2012-01-31 |
|
| 2011-10-31 |
|
| 2011-07-31 |
|
| 2011-04-30 |
|
| 2011-01-31 |
|
| 2010-10-31 |
|
| 2010-07-31 |
|
| 2010-04-30 |
|
| 2010-01-31 |
|
| 2009-10-31 |
|
| 2009-07-31 |
|
| 2009-04-30 |
|
| 2009-01-31 |
|
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical & Dental Supplies |
$18.615B |
$3.895B |
|
The Cooper Companies Inc, is a specialty medical device company operating on a global basis. Cooper has two business segments- CooperVision and CooperSurgical. CooperVision manufactures and sells a wide range of contact lenses. CooperVision develops manufactures and markets a broad range of single-use, two-week and monthly contact lenses, featuring advanced materials and optics. The company's products are primarily designed for solving vision challenges like astigmatism, presbyopia and ocular dryness.?CooperSurgical sells a variety of medical devices and surgical instruments that are primarily utilized by gynecologists and obstetricians.
|
